Position in LGND
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,969,535
+$3,213,084 QoQ
Shares Held
29,900
+105.1% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 53.94648829431438.ToString("F0")%
Shared 0.ToString("F0")%
None 46.053511705685615.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. LGND ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,502 | $29,748,185 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,092 | $14,330,361 | |
| 3 | EXEL |
Exelixis, Inc.
|
312,296 | $13,394,375 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
121,088 | $7,825,917 | |
| 5 | CELC |
Celcuity Inc.
|
61,068 | $6,970,301 | |
| 6 | RPRX |
Royalty Pharma plc
|
143,760 | $6,896,167 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
This page
|
29,900 | $5,969,535 | |
| 8 | INCY |
Incyte Corp
|
53,555 | $5,040,596 |
All Filings in LGND
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,969,535 | 29,900 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,756,451 | 14,579 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,658,694 | 15,009 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $1,774,431 | 15,609 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,245,067 | 11,842 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,289,443 | 12,034 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,223,299 | 12,222 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,064,119 | 12,629 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $491,012 | 6,717 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $451,017 | 6,315 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $358,621 | 5,985 | Shares | Sole | 2023-11-15 | |
| 2022-06-30 | $50,203 | 902 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $62,595 | 892 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $128,829 | 1,337 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $131,150 | 1,509 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $120,632 | 1,474 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $140,276 | 1,475 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,320 | 118 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,719 | 113 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $40,679 | 583 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $74,035 | 1,632 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||